Adient (ADNT) EVP reports 3,667-share RSU vesting on Form 4

Adient plc (ADNT) executive Jian James Huang reported the vesting of 3,667 restricted stock units on a Form 4.

Rhea-AI Filing Summary

Adient plc (ADNT) executive Jian James Huang reported the vesting of 3,667 restricted stock units on a Form 4. On November 17, 2025, 3,667 ordinary shares were acquired at a stated price of $0 in connection with the RSU vesting and an equal number of ordinary shares were disposed of at $19.05 per share, leaving 0 ordinary shares directly beneficially owned after the reported transactions. The filing notes that the restricted share units were settled in cash rather than in stock.

Insider Trade Summary

3,667 shares exercised/converted

Exercise 3 txns

Insider Huang Jian James

Role EVP, APAC

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	3,667	$0.00	$0.00
Exercise	Ordinary Shares	3,667	$0.00	$0.00
Disposition	Ordinary Shares	3,667	$19.05	$70K

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Ordinary Shares — 0 shares (Direct)

Footnotes (1)

1. F1. Reflects vesting of restricted share units, which were settled in cash, on November 17, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Adient (ADNT) report for Jian James Huang?

Adient plc reported that EVP, APAC Jian James Huang had 3,667 restricted stock units vest on November 17, 2025, with related ordinary share acquisition and disposition reported on Form 4.

How many Adient (ADNT) shares were involved in Jian James Huang's Form 4 filing?

The Form 4 shows 3,667 ordinary shares acquired at a stated price of $0 and 3,667 ordinary shares disposed at $19.05 per share on November 17, 2025.

Did Jian James Huang retain any Adient (ADNT) shares after the reported transaction?

No. Following the reported acquisition and disposition of ordinary shares tied to the RSU vesting, the filing lists 0 ordinary shares as directly beneficially owned.

How were the restricted stock units for Adient (ADNT) settled in Jian James Huang's transaction?

The explanation states that the transaction reflects the vesting of restricted share units, which were settled in cash on November 17, 2025.

What role does the reporting person hold at Adient (ADNT)?

The reporting person, Jian James Huang, is identified as an Officer of Adient plc with the title EVP, APAC.

Is this Adient (ADNT) Form 4 filed for one reporting person or multiple?

The filing is indicated as a Form filed by one reporting person, covering the transactions of EVP, APAC Jian James Huang only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huang Jian James

(Last) (First) (Middle)

49200 HALYARD DRIVE

(Street)

PLYMOUTH MI 48170

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Adient plc [ ADNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, APAC

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/17/2025		M		3,667	A	$0(1)	3,667	D
Ordinary Shares	11/17/2025		D		3,667	D	$19.05(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	11/17/2025		M			3,667	(1)	(1)	Ordinary Shares	3,667	$0	0	D

Explanation of Responses:

1. Reflects vesting of restricted share units, which were settled in cash, on November 17, 2025.

Remarks:

	/s/ Brett L. Eilander, attorney-in-fact for Jian James Huang	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.